Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
08.02.2023 17:40:00

NEURONES: 14.2% organic growth in 2022

PRESS RELEASE
Heading: 2022 annual revenues        Nanterre, 8 February 2023 (after trading)

14.2% organic growth in 2022

(not audited, in millions of euros)20212022growthof which organic
Revenues579.9665.4+ 14.7%+ 14.2%

Achievements

The 2022 revenues came to €665.4m (up 14.7%), topping the latest forecasts after gathering pace in the latter part of the year (+ 17.3% in the 4th quarter).

The Consulting and Applications segments are driving growth, in particular digital and data-centered projects. Moreover, the most buoyant businesses are migration to the various cloud architectures, enhancement of the work environment and the "employee experience”, and cybersecurity.

At €72.9 million *, operating profit also rose sharply (up 18.4%, following an 18.7% increase the previous year). In percentage terms, it reached a record level of 11% of revenues.

The group's growth was primarily driven by a net recruitment of more than 500 people, and increased use of subcontractors.

The full final annual results will be published on Wednesday, March 8, 2023 after the closing of the stock exchange.

Outlook

For 2023, the Group will benefit from significant embedded growth. As usual, the forecasts for 2023 will be posted along with the Group's 1st quarter revenues.

* currently being audited.

About NEURONES
With 6,500 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) - Euronext Tech Leaders – DSS mid-caps
www.neurones.net

Press Relations:
O'Connection
Valérie Hackenheimer
Tel.: +33 (0)6 12 80 35 20

vhackenheimer@oconnection.fr


NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
rp@neurones.net
Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
investisseurs@neurones.net

Attachment


Nachrichten zu NeuronesAct.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu NeuronesAct.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

NeuronesAct. 44,10 2,20% NeuronesAct.